Bryan Johnson Launches $1M Annual 'Immortals' Longevity Program with AI-Powered Health Concierge

13.02.2026

Longevity entrepreneur and former fintech founder Bryan Johnson has announced the launch of "Immortals," an exclusive health optimization program priced at $1 million annually, with only three enrollment slots available.

The premium offering represents Johnson's most ambitious venture into the longevity market, packaging the proprietary health protocol he has personally followed over the past five years. The program includes several high-touch components:

• Dedicated concierge medical team
• 24/7 access to BryanAI, an artificial intelligence health assistant
• Comprehensive diagnostic testing and biological data analysis
• Continuous health metrics monitoring
• Advanced dermatological and hair restoration protocols
• Access to cutting-edge therapeutic interventions

For clients unable to commit to the seven-figure price point, Johnson offers a "supported tier" at $60,000 annually, though specific details about this alternative remain limited.

The Growing Longevity Tech Market

Johnson's launch reflects broader momentum in the preventative health and longevity sector among high-net-worth individuals. Several competing platforms have emerged:

• Biograph, co-founded by John Hering, offers preventative diagnostics with premium memberships at $15,000 annually
• Fountain Life has secured $108 million in funding for its longevity platform, charging $21,500 per year for comprehensive services

While Johnson's pricing significantly exceeds competitor offerings, the exclusive three-slot availability creates artificial scarcity that may appeal to ultra-high-net-worth individuals seeking differentiated health optimization strategies.

Market Positioning and Accessibility

The "Immortals" program sits at the apex of an increasingly stratified longevity market. For consumers priced out of premium tiers, Johnson's Blueprint brand offers consumer products including specialty olive oil and nutritional supplements, creating multiple revenue streams across different market segments.

Industry observers note that while evidence-based preventative health practices offer legitimate benefits, the extreme protocols and premium pricing in this sector raise questions about accessibility and the democratization of longevity science.

Tags: wellness longevity healthtech AI biotech

Share: VK Telegram Twitter